I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

Splitero reports on strategies for managing post-holiday debt, comparing home equity and credit card options to reduce ...

The introduction of digital veteran cards could provide a crucial "case study" for how such credentials operate, potentially ...